Kathryn Geron
Family Medicine · Rogersville, MONPI 1326335159
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 304 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,737 and has fallen 96.7% since, to $58 in 2025.
Across 304 payments — averaging $11.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$494
- AbbVie$334
- AstraZeneca$308
- Novo Nordisk$304
- GSK$252
- Daiichi Sankyo Inc.$222
- plus $1K from 23 others
What the payments were for
- Food & beverage$3,29397%
- Education$1003%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 62 | $494 |
| AbbVie(2 entities) | 45 | $334 |
| AstraZeneca | 16 | $308 |
| Novo Nordisk | 27 | $304 |
| GSK | 28 | $252 |
| Daiichi Sankyo Inc. | 12 | $222 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $217 |
| Boehringer Ingelheim | 14 | $192 |
| Merck | 16 | $181 |
| Lilly USA, LLC | 12 | $160 |
| Teva Pharmaceuticals USA, Inc. | 13 | $122 |
| Astellas Pharma US Inc | 4 | $114 |
| Amarin Pharma, Inc. | 3 | $51 |
| Circassia Inc. | 3 | $49 |
| Otsuka America Pharmaceutical, Inc. | 3 | $45 |
| Amgen | 3 | $44 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $42 |
| Novartis | 3 | $40 |
| Johnson & Johnson | 3 | $38 |
| Radius Health, Inc. | 2 | $31 |
| Arbor Pharmaceuticals, Inc. | 2 | $30 |
| Edwards Lifesciences | 1 | $23 |
| Dexcom, Inc. | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| Collegium Pharmaceutical, Inc. | 1 | $13 |
| Mylan Specialty L.p. | 1 | $13 |
| Genentech USA, Inc. | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
How this compares
$3,393 in reported general payments places this provider in the 80th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Rogersville
- Stephen AdamsSpringfield$636K
- Justin PuckettKirksville$568K
- Matthew BeckerditeOfallon$225K
- Roger CadySpringfield$175K
- James LasalleExcelsior Springs$130K
- Matthew TiefenbrunnSullivan$105K
- Ayobami OduwoleGrandview$92K
- Michael DonovanSaint Louis$78K
- Blair ThedingerKansas City$71K
- Christine MooreRaymore$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.